Users' guides to the medical literature: VI. How to use an overview

…, A Holbrook, R Jaeschke, E Juniper, A Laupacis… - Jama, 1994 - jamanetwork.com
CLINICAL SCENARIO A 55-year-old man had his serum cholesterol level measured at a
shopping mall 2 months ago. His cholesterol level was elevated and he comes to you, his …

Antithrombotic therapy in atrial fibrillation

GW Albers, JE Dalen, A Laupacis, WJ Manning… - Chest, 2001 - journal.chestnet.org
Study Design During the last decade, many studies7–25 assessing the efficacy and safety
of different antithrombotic therapies for the prevention of stroke in AF have been published (…

Rules of evidence and clinical recommendations on the use of antithrombotic agents

DJ Cook, GH Guyatt, A Laupacis, DL Sackett - Chest, 1992 - journal.chestnet.org
What rnles of evidence should apply when expert committees meet to generate recommendations
for the clinical management of patients? Should only the thoroughly validated results …

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

…, KF Schulz, WR Parulekar, K Krleža-Jerić, A Laupacis… - Bmj, 2013 - bmj.com
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …

SPIRIT 2013 statement: defining standard protocol items for clinical trials

…, JM Tetzlaff, DG Altman, A Laupacis… - Annals of internal …, 2013 - acpjournals.org
The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting,
and appraisal. However, trial protocols and existing protocol guidelines vary greatly in …

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

…, L Laine, A Lanas, P Lance, A Laupacis… - Lancet (London …, 2013 - europepmc.org
Background The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs
(NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-…

Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention B. What Were the Results and Will They Help Me in Caring for My …

…, A Holbrook, R Jaeschke, E Juniper, A Laupacis… - Jama, 1994 - jamanetwork.com
CLINICAL SCENARIO You are a general internist who is asked to see a 65-year-old man with
controlled hypertension and a 6-month history of atrial fibrillation resistant to cardioversion…

An assessment of clinically useful measures of the consequences of treatment

A Laupacis, DL Sackett… - New England journal of …, 1988 - Mass Medical Soc
WITH neither the time nor the resources available to prevent, detect, or treat every disorder
in every patient, which preventive, diagnostic, or therapeutic interventions should take priority…

[HTML][HTML] Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

…, DS Lee, A Kopp, PC Austin, A Laupacis… - … England Journal of …, 2004 - Mass Medical Soc
Background The Randomized Aldactone Evaluation Study (RALES) demonstrated that
spironolactone significantly improves outcomes in patients with severe heart failure. Use of …

The Canadian CT Head Rule for patients with minor head injury

…, K Vandemheen, C Clement, H Lesiuk, A Laupacis… - The Lancet, 2001 - thelancet.com
Background There is much controversy about the use of computed tomography (CT) for
patients with minor head injury. We aimed to develop a highly sensitive clinical decision rule for …